Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Iucrj
|
January 23, 2015
Data to knowledge: how to get meaning from your result
Helen M Berman, Margaret J Gabanyi, Colin R Groom, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 3, 2019
Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent
Ricardo Gallardo-Macias, Pradeep Kumar, Mark Jaskowski, et al.
The Journal of Infectious Diseases
|
January 27, 2021
Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model
Elise D Pieterman, Lina Keutzer, Aart van der Meijden, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2021
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
Uday S Ganapathy, Rubén González Del Río, Mónica Cacho-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy
|
January 23, 2023
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection
Dereje A Negatu, Rubén González Del Río, Mónica Cacho-Izquierdo, et al.
Plos Pathogens
|
April 27, 2018
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis
Yitian Xu, Lihua Wang, Matthew D Zimmerman, et al.
Antimicrobial Agents and Chemotherapy
|
August 25, 2022
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
Abdeldjalil Madani, Dereje A Negatu, Abdellatif El Marrouni, et al.
The Journal of Biological Chemistry
|
May 17, 2008
A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats
Natalia Beloglazova, Greg Brown, Matthew D Zimmerman, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2018
Novel Pyrimidines as Antitubercular Agents
Daigo Inoyama, Steven D Paget, Riccardo Russo, et al.
Antimicrobial Agents and Chemotherapy
|
July 12, 2021
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis
Jacqueline P Ernest, Jansy Sarathy, Ning Wang, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Iucrj
|
January 23, 2015
Data to knowledge: how to get meaning from your result
Helen M Berman, Margaret J Gabanyi, Colin R Groom, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 3, 2019
Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent
Ricardo Gallardo-Macias, Pradeep Kumar, Mark Jaskowski, et al.
The Journal of Infectious Diseases
|
January 27, 2021
Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model
Elise D Pieterman, Lina Keutzer, Aart van der Meijden, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2021
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
Uday S Ganapathy, Rubén González Del Río, Mónica Cacho-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy
|
January 23, 2023
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection
Dereje A Negatu, Rubén González Del Río, Mónica Cacho-Izquierdo, et al.
Plos Pathogens
|
April 27, 2018
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis
Yitian Xu, Lihua Wang, Matthew D Zimmerman, et al.
Antimicrobial Agents and Chemotherapy
|
August 25, 2022
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
Abdeldjalil Madani, Dereje A Negatu, Abdellatif El Marrouni, et al.
The Journal of Biological Chemistry
|
May 17, 2008
A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats
Natalia Beloglazova, Greg Brown, Matthew D Zimmerman, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2018
Novel Pyrimidines as Antitubercular Agents
Daigo Inoyama, Steven D Paget, Riccardo Russo, et al.
Antimicrobial Agents and Chemotherapy
|
July 12, 2021
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis
Jacqueline P Ernest, Jansy Sarathy, Ning Wang, et al.
Page
of 9